Navigation Links
Collagen Matrix, Inc. Receives FDA 510(k) Clearance for SynOss(TM) Synthetic Mineral Bone Graft Material
Date:11/5/2007

FRANKLIN LAKES, N.J., Nov 5. /PRNewswire/ -- Collagen Matrix, Inc. announces that it has received FDA's 510(k) clearance of its SynOss(TM) Synthetic Mineral bone graft material intended for use in oral surgical applications involving bone repair.

SynOss Synthetic Mineral is an osteoconductive calcium phosphate based bone graft material with an apatite structure similar to that of human bone. Unlike hydroxyapatite materials, SynOss' has a carbonate apatite structure which is comparable to the mineralized matrix structure of human bone. The similarity in structure between SynOss and natural bone mineral allows for SynOss' in vivo resorption and remodeling profile to mimic that of natural bone.

The synthetic mineral product is complementary to the Company's existing line of products intended for dental and oral surgery, which include Collagen Dental Membranes, Anorganic Bone Mineral, Anorganic Bone Mineral with Collagen, and Collagen Dental Wound Dressings in various forms (i.e., Foam, Tape, Plug, and Microfibrillar). These products are sold through partnerships with major companies in the dental market.

"Our goal is to provide the dental and oral surgical markets with a full line of innovative products for use in regenerative medicine. The addition of SynOss is another step in reaching that goal," said Shu-Tung Li, Ph.D., Founder and CEO of Collagen Matrix.

About Collagen Matrix

A Franklin Lakes, NJ based, privately-held, leading collagen- and mineral-based biomaterials company, Collagen Matrix, Inc. has applied its expertise in proprietary matrix engineering to develop and commercialize novel implants for tissue and organ repair and regeneration. The Company currently manufactures collagen- and mineral-based finished medical devices in areas of oral surgery, neurosurgery, orthopedic-spine surgery, and wound care. Over 20 products are currently being marketed directly or through partnerships with some of the world's major medical device companies. In addition to the products in the oral surgical area, Collagen Matrix's marketed products include: DuraMatrix(TM) for dural repair, Neuroflex(TM), NeuroMatrix(TM) for peripheral nerve repair, OssiMend(TM) for bone repair in orthopedics and spine, and the Matrix Collagen Family of Products for wound care. For more information, visit http://www.collagenmatrix.com.

Contact:

Shu-Tung Li, Ph.D.

888-405-1001

201-405-1477


'/>"/>
SOURCE Collagen Matrix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... responds to and which He does not. Yisrayl says with so many titles and ... true name, but he says with a little Scripture, backed with a lot of research, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the ... implement a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software ... in long-term care, Brooke Grove now has the capability to achieve its goal ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Rob Lowe is ... now he has leant his presence to an educational purpose as the host of ... important one being cancer. In a recent episode, the series focuses on thyroid cancer. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017 The Mobile X-Ray product segment is ... CAGR during the forecast period Mobile X-Ray segment ... digital mobile X-Ray devices market, which is estimated to be ... at a CAGR of 7% over the forecast period. Mobile ... more than US$ 100 Mn in 2017 over 2016. The ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology: